New Indications and Dosage Forms for 2003

See also: New Drug Approvals for 2003

May 20, 2003

FDA Approves Gleevec for Pediatric Leukemia Treatment

October 29, 2003

Risperdal Consta Approved for Schizophrenia

December 8, 2003

FDA Converts Gleevec in Second Line Setting to Regular Approval

New indications and dosage forms archive

Recently Approved

Wayrilz
Wayrilz (rilzabrutinib) is a kinase inhibitor indicated for the treatment of...
Dawnzera
Dawnzera (donidalorsen) is a prekallikrein-directed antisense oligonucleotide...
Tonmya
Tonmya (cyclobenzaprine hydrochloride) is a sublingual formulation of...

More drug approvals